Evaluating the therapeutic potential of BSA-reduced mussel-derived selenium nanoparticles to mitigate copper sulfate-induced hepatic damage and neurodegeneration in a zebrafish model

IntroductionLiver fibrosis is the abnormal accumulation of extracellular matrix and eventual formation of fibrous scar in response to chronic liver injury, which can be triggered by increased levels of reactive oxygen species. The brain-liver axis is a crucial communication pathway that significantl...

Full description

Saved in:
Bibliographic Details
Main Authors: Suganiya Umapathy, Ieshita Pan
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2025.1522370/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849310358275096576
author Suganiya Umapathy
Ieshita Pan
author_facet Suganiya Umapathy
Ieshita Pan
author_sort Suganiya Umapathy
collection DOAJ
description IntroductionLiver fibrosis is the abnormal accumulation of extracellular matrix and eventual formation of fibrous scar in response to chronic liver injury, which can be triggered by increased levels of reactive oxygen species. The brain-liver axis is a crucial communication pathway that significantly influences the intricate interactions between hepatic function and brain health. Selenium, as a source of selenoproteins, plays a vital role in antioxidant defense systems. The extraction of selenium from mussels leverages their natural bioaccumulation, providing a biocompatible source. Selenium nanoparticles are known for their potential antioxidant activity and can be employed to regulate ROS levels to overcome hepatic damage.MethodsSelenium nanoparticles were synthesized from mussel-extracted selenium and stabilized with bovine serum albumin. The zebrafish models exposed to copper sulfate were treated with selenium nanoparticles (5-25 μg/ml). This study evaluated their potential role as antioxidants against hepatic damage induced by copper sulfate in vivo in the zebrafish model.ResultsThe bovine serum albumin stabilized selenium nanoparticles reduced for 30 minutes and 1 hour were spherical with a size of 19 and 16 nm. Stabilized selenium nanoparticles reduced for 30 minutes (25 μg/ml) showed significant in vitro reactive oxygen species scavenging activity and improved in vivo antioxidant enzyme levels by decreasing lipid peroxidation and nitric oxide levels. Histopathological examination revealed a delay in the progression of copper sulfate-induced hepatic damage, and upregulated the expression of antioxidants, while the hepatic and mitochondrial damage markers were downregulated.ConclusionIn conclusion, bovine serum albumin-reduced selenium nanoparticles can be a promising therapeutic antioxidant for protecting against reactive oxygen species-induced hepatic damage and neurodegeneration.
format Article
id doaj-art-35baa658a42b4d878dd82a65077b6d74
institution Kabale University
issn 1664-8021
language English
publishDate 2025-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genetics
spelling doaj-art-35baa658a42b4d878dd82a65077b6d742025-08-20T03:53:46ZengFrontiers Media S.A.Frontiers in Genetics1664-80212025-05-011610.3389/fgene.2025.15223701522370Evaluating the therapeutic potential of BSA-reduced mussel-derived selenium nanoparticles to mitigate copper sulfate-induced hepatic damage and neurodegeneration in a zebrafish modelSuganiya UmapathyIeshita PanIntroductionLiver fibrosis is the abnormal accumulation of extracellular matrix and eventual formation of fibrous scar in response to chronic liver injury, which can be triggered by increased levels of reactive oxygen species. The brain-liver axis is a crucial communication pathway that significantly influences the intricate interactions between hepatic function and brain health. Selenium, as a source of selenoproteins, plays a vital role in antioxidant defense systems. The extraction of selenium from mussels leverages their natural bioaccumulation, providing a biocompatible source. Selenium nanoparticles are known for their potential antioxidant activity and can be employed to regulate ROS levels to overcome hepatic damage.MethodsSelenium nanoparticles were synthesized from mussel-extracted selenium and stabilized with bovine serum albumin. The zebrafish models exposed to copper sulfate were treated with selenium nanoparticles (5-25 μg/ml). This study evaluated their potential role as antioxidants against hepatic damage induced by copper sulfate in vivo in the zebrafish model.ResultsThe bovine serum albumin stabilized selenium nanoparticles reduced for 30 minutes and 1 hour were spherical with a size of 19 and 16 nm. Stabilized selenium nanoparticles reduced for 30 minutes (25 μg/ml) showed significant in vitro reactive oxygen species scavenging activity and improved in vivo antioxidant enzyme levels by decreasing lipid peroxidation and nitric oxide levels. Histopathological examination revealed a delay in the progression of copper sulfate-induced hepatic damage, and upregulated the expression of antioxidants, while the hepatic and mitochondrial damage markers were downregulated.ConclusionIn conclusion, bovine serum albumin-reduced selenium nanoparticles can be a promising therapeutic antioxidant for protecting against reactive oxygen species-induced hepatic damage and neurodegeneration.https://www.frontiersin.org/articles/10.3389/fgene.2025.1522370/fullliver fibrosisreactive oxygen speciesselenium nanoparticlesantioxidantzebrafish
spellingShingle Suganiya Umapathy
Ieshita Pan
Evaluating the therapeutic potential of BSA-reduced mussel-derived selenium nanoparticles to mitigate copper sulfate-induced hepatic damage and neurodegeneration in a zebrafish model
Frontiers in Genetics
liver fibrosis
reactive oxygen species
selenium nanoparticles
antioxidant
zebrafish
title Evaluating the therapeutic potential of BSA-reduced mussel-derived selenium nanoparticles to mitigate copper sulfate-induced hepatic damage and neurodegeneration in a zebrafish model
title_full Evaluating the therapeutic potential of BSA-reduced mussel-derived selenium nanoparticles to mitigate copper sulfate-induced hepatic damage and neurodegeneration in a zebrafish model
title_fullStr Evaluating the therapeutic potential of BSA-reduced mussel-derived selenium nanoparticles to mitigate copper sulfate-induced hepatic damage and neurodegeneration in a zebrafish model
title_full_unstemmed Evaluating the therapeutic potential of BSA-reduced mussel-derived selenium nanoparticles to mitigate copper sulfate-induced hepatic damage and neurodegeneration in a zebrafish model
title_short Evaluating the therapeutic potential of BSA-reduced mussel-derived selenium nanoparticles to mitigate copper sulfate-induced hepatic damage and neurodegeneration in a zebrafish model
title_sort evaluating the therapeutic potential of bsa reduced mussel derived selenium nanoparticles to mitigate copper sulfate induced hepatic damage and neurodegeneration in a zebrafish model
topic liver fibrosis
reactive oxygen species
selenium nanoparticles
antioxidant
zebrafish
url https://www.frontiersin.org/articles/10.3389/fgene.2025.1522370/full
work_keys_str_mv AT suganiyaumapathy evaluatingthetherapeuticpotentialofbsareducedmusselderivedseleniumnanoparticlestomitigatecoppersulfateinducedhepaticdamageandneurodegenerationinazebrafishmodel
AT ieshitapan evaluatingthetherapeuticpotentialofbsareducedmusselderivedseleniumnanoparticlestomitigatecoppersulfateinducedhepaticdamageandneurodegenerationinazebrafishmodel